Literature DB >> 2564084

Debrisoquine hydroxylation polymorphism and personality.

L Bertilsson, C Alm, C De Las Carreras, J Widen, G Edman, D Schalling.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2564084     DOI： 10.1016/s0140-6736(89)90094-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  21 in total

Review 1.  Polymorphic cytochromes P450 and drugs used in psychiatry.

Authors:  R T Coutts; L J Urichuk
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

Review 2.  Phenotyping of Human CYP450 Enzymes by Endobiotics: Current Knowledge and Methodological Approaches.

Authors:  Gaëlle Magliocco; Aurélien Thomas; Jules Desmeules; Youssef Daali
Journal:  Clin Pharmacokinet       Date:  2019-11       Impact factor: 6.447

3.  No association between CYP2D6 polymorphisms and personality trait in Japanese.

Authors:  Kumiko Iwashima; Norio Yasui-Furukori; Ayako Kaneda; Manabu Saito; Taku Nakagami; Yasushi Sato; Sunao Kaneko
Journal:  Br J Clin Pharmacol       Date:  2007-02-23       Impact factor: 4.335

4.  Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2008-07-30       Impact factor: 7.853

Review 5.  CYP2D6 variation, behaviour and psychopathology: implications for pharmacogenomics-guided clinical trials.

Authors:  Eva M Peñas-Lledó; Adrián Llerena
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

6.  N-acetylation and debrisoquine hydroxylation polymorphisms in patients with Gilbert's syndrome.

Authors:  W Siegmund; J D Fengler; G Franke; M Zschiesche; O Eike; E Eike; P Meisel; R Wulkow
Journal:  Br J Clin Pharmacol       Date:  1991-10       Impact factor: 4.335

7.  Sensation seeking amongst healthy volunteers participating in phase I clinical trials.

Authors:  M Farré; X Lamas; J Camí
Journal:  Br J Clin Pharmacol       Date:  1995-04       Impact factor: 4.335

Review 8.  Interethnic differences in drug metabolism: influence of genetic and environmental factors on debrisoquine hydroxylation phenotype.

Authors:  A Llerena; J Cobaleda; C Martínez; J Benítez
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1996 Apr-Jun       Impact factor: 2.441

9.  CYP2D6 genotype is not associated with survival in breast cancer patients treated with tamoxifen: results from a population-based study.

Authors:  D L Hertz; K M Kidwell; S G Hilsenbeck; S Oesterreich; C K Osborne; S Philips; C Chenault; R J Hartmaier; T C Skaar; M J Sikora; J M Rae
Journal:  Breast Cancer Res Treat       Date:  2017-07-20       Impact factor: 4.872

10.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.